Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-10-18
1997-04-29
Bernhardt, Emily
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544383, 560 39, 548542, A61K 31495, C07D24118
Patent
active
056249284
ABSTRACT:
There is disclosed a method of synthesizing a compound of the formula ##STR1## and novel analogs of the formula ##STR2## where R and R.sub.1 are fully defined. These compounds exhibit beneficial antiviral properties especially as inhibitors of the influenza virus.
REFERENCES:
Goetz et al, Chemical Abstracts, vol. 122, No. 235152 (1995) (Abstract for GB 2,280,435, Feb. 1, 1995).
Hensens et al, Tetrahedron Letters 36, pp. 2005-2008 (1995).
Singh, Tetrahedron Letters, 36, pp. 2009-2012 (1995).
Drug Evaluations Annual 1993 by American Medical Association, pp. 1723-1724, 1735-1736, (1993).
Bernhardt Emily
Daniel Mark R.
Korsen Elliott
Merck & Co. , Inc.
LandOfFree
Method of synthesizing an endonuclease inhibitor and analogs the does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of synthesizing an endonuclease inhibitor and analogs the, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of synthesizing an endonuclease inhibitor and analogs the will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-705903